Effect of pancreatic polypeptide on rat dorsal vagal complex neurons.
1. Pancreatic polypeptide (PP) microinjected into the dorsal vagal complex (DVC) elevates gastric activity through a vagal mechanism. Thus, it was hypothesized that PP alters the activity of nuclei comprising the DVC, i.e. the nucleus tractus solitarii (NTS) and the dorsal motor nucleus (DMN). 2. In vivo and in vitro approaches were used. For in vivo studies, micropipettes were used for recording and injecting vehicle or PP. Neurons were identified as NTS or DMN using orthodromic and antidromic activation, respectively, following vagal stimulation. Gastric-related DVC neurons were located using antral inflation. For in vitro studies, DMN neurons were recorded from medullary slices. 3. Of the twenty-eight NTS and DMN neurons identified, fifteen were activated, six inhibited and seven unaffected after PP microinjection. Forty-two gastric-related neurons were located in the DVC, of which twenty-five were stimulated by PP and seventeen exhibited no change. No gastric-related cells were inhibited. 4. For in vitro studies, 66% of DMN neurons were activated by PP (n = 27/47) while the remaining 33% were inhibited (n = 14/47). Similar results were obtained in normal or synaptic blockade media. 5. These results support the hypothesis that PP alters DVC neuronal activity, which may thereby lead to the previously observed alterations in gastric activity.
McTigue
D M
DM
Department of Physiology, College of Medicine, Ohio State University, Columbus 43210, USA. mctigue.2@osu.edu
Hermann
G E
GE
Rogers
R C
RC
D000818:Animals; D004594:Electrophysiology; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D010191:Pancreatic Polypeptide / Q000494:pharmacology*; D051381:Rats; D017552:Solitary Nucleus / Q000187:drug effects / Q000502:physiology; D014630:Vagus Nerve / Q000166:cytology* / Q000502:physiology
D010191:Pancreatic Polypeptide